Pancreatic Cancer Research

ResearcherUniversity of LiverpoolActive in the last 2 years

Daniel H. Palmer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7147-5703; OpenAlex author ID A5054153408, A5126775467. Sources: ClinicalTrials.gov.

Their work

Papers
5 (first author 1, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 5

  1. New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer. Co-author DOI 10.1038/s41416-025-03295-9↗
  2. Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service. Last author DOI 10.1038/s41416-026-03341-0↗
  3. NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. Co-author DOI 10.1093/jnci/djaf345↗
  4. Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis. Co-author DOI 10.1093/bjsopen/zrae172↗
  5. Metastatic pancreatic cancer: a new standardised dose-reduction regimen? First author DOI 10.1016/s2468-1253(24)00227-9↗

Trials 1

  1. Acelarin First Line Randomised Pancreatic Study Principal investigator NCT03610100↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paula Ghaneh · 4 shared papers, 2024–2026 · strength 1.19
  2. John P. Neoptolemos · 3 shared papers, 2026 · strength 0.78
  3. Christopher Michael Halloran · 3 shared papers, 2025–2026 · strength 0.73
  4. Markus Wolfgang Büchler · 2 shared papers, 2026 · strength 0.52
  5. Thilo Hackert · 2 shared papers, 2026 · strength 0.52
  6. Christoph Springfeld · 2 shared papers, 2026 · strength 0.52
  7. Christoph W. Michalski · 2 shared papers, 2026 · strength 0.52
  8. Thomas P. Hank · 1 shared paper, 2026 · strength 0.30
  9. Daniel Öhlund · 1 shared paper, 2026 · strength 0.30
  10. Olusola Olusesan Faluyi · 1 shared paper, 2026 · strength 0.26
  11. Martyn Charles Stott · 1 shared paper, 2026 · strength 0.26
  12. Jessica Hale · 1 shared paper, 2026 · strength 0.26
  13. Luke Dickerson · 1 shared paper, 2025 · strength 0.26
  14. Michael C. Schmid · 1 shared paper, 2025 · strength 0.26
  15. Ainhoa Mielgo Iza · 1 shared paper, 2025 · strength 0.26
  16. Lucy S. Oldfield · 1 shared paper, 2026 · strength 0.22
  17. Pedro Antonio Pérez-Mancera · 1 shared paper, 2026 · strength 0.22
  18. Lawrence N. Barrera · 1 shared paper, 2026 · strength 0.22
  19. Kate Murray · 1 shared paper, 2026 · strength 0.22
  20. Dylan Williams · 1 shared paper, 2026 · strength 0.22
  21. William Greenhalf · 1 shared paper, 2026 · strength 0.22
  22. Eithne Costello · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.